2021 SHAREHOLDER’S GUIDE

Innovating to adapt to the needs of customers and patients

Our strategy is based on the results that are important to the patient, offset against the cost of achieving this.

These are key to developing a personalized approach to treatment, in cooperation with the prescribing doctor. An approach which takes into account a patient’s physiological data, lifestyle and family situation. In this respect, the patient is at the heart of the system, and the entire healthcare ecosystem benefits from this: the doctor can rely on Air Liquide's teams to monitor the observance of treatment, healthcare coverage organizations see a significant decrease in the cost of overall care and pressure is taken off the hospitals.

From theory to practice

"At Air Liquide, we have launched an ambitious program to transform our activities in order to introduce this new value-based approach. Twelve of the Group’s countries in Europe have set their own targets in terms of optimizing the continuum of care, creating specialized offers for each pathology and forming strategic partnerships, as it is important to bring together the entire ecosystem,” explains Dolores Paredes.

The success of this international project depends, in particular, on the creation of a digital platform to facilitate the measurement and monitoring of results from the care provided and the related costs.

Several initiatives have already been launched in all of these countries. For example, in Sweden, our subsidiary Nordic Infucare has launched Birgitta, a services transformation program for patients suffering from diabetes or Parkinson's disease. For the latter, the new and resolutely proactive care model focuses on the “3Ps”: Prediction (when the patient requires care and attention), Prescription (what is the most suitable treatment) and Prevention (how to slow the progression of the illness). "Our flagship program, and the most advanced, PIMA(3), has been endorsed by the Value Based Healthcare Center Europe(4),” welcomed Dolores Paredes.

This program is based on an obvious observation: each patient with sleep apnea is different, therefore why offer the same support to them all? By customizing the approach, the goal is to increase the adherence to treatment and ultimately improve the patient's quality of life. This initiative, which was first launched in Spain, has already been adapted for patients in Portugal, Italy, Belgium and the Netherlands. In France, an agreement with the Chair of “Innovation and Value in Health” at the University of Paris School of Medicine has been reached, aimed at supporting academic research into this new approach, in particular for chronic diseases. At the same time, patients in ten countries have been surveyed in order to better understand their expectations in terms of results. After all, surely the patients are the best placed to teach us how to restore meaning and value to care? The floor is theirs. And this is just the beginning.

1.8 M

patients are treated by Air Liquide worldwide

(3) A personalized program for improved patient adherence.

(4) A European organization which brings together healthcare players (doctors, patient associations, universities, industrial players, insurers, etc.) with the aim of encouraging the implementation of a renewed healthcare approach based on value, through the development of new methods and by sharing best practices among healthcare players.